[Current advances in leprosy research activities]
- PMID: 15745061
- DOI: 10.5025/hansen.74.3
[Current advances in leprosy research activities]
Abstract
Due to the advent of multi-drug therapy (MDT) recommended by the WHO, for the treatment of leprosy, presently, leprosy is regarded as a "curable disease". The number of new cases in Japan is relatively very low, due to which the disease is likely to be neglected, but on scientific grounds, there is a necessity to perform in depth studies. Leprosy caused by M. leprae is still unclear on various aspects including transmission, immunology, nerve damage etc. Here we introduce the recent advances in the field of basic leprosy research.
Similar articles
-
The continuing challenges of leprosy.Clin Microbiol Rev. 2006 Apr;19(2):338-81. doi: 10.1128/CMR.19.2.338-381.2006. Clin Microbiol Rev. 2006. PMID: 16614253 Free PMC article. Review.
-
Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.Int J Lepr Other Mycobact Dis. 1993 Mar;61(1):51-8. Int J Lepr Other Mycobact Dis. 1993. PMID: 8326181
-
Interaction of Mycobacterium leprae with the HaCaT human keratinocyte cell line: new frontiers in the cellular immunology of leprosy.Exp Dermatol. 2015 Jul;24(7):536-42. doi: 10.1111/exd.12714. Epub 2015 May 4. Exp Dermatol. 2015. PMID: 25828729
-
A longitudinal study of immunologic reactivity in leprosy patients treated with immunotherapy.Int J Lepr Other Mycobact Dis. 1994 Dec;62(4):552-8. Int J Lepr Other Mycobact Dis. 1994. PMID: 7868953
-
Molecular basis for the peripheral nerve predilection of Mycobacterium leprae.Curr Opin Microbiol. 2001 Feb;4(1):21-7. doi: 10.1016/s1369-5274(00)00159-4. Curr Opin Microbiol. 2001. PMID: 11173029 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical